COMP · Western blot design guide

Design a Western Blot for COMP

Real validated COMP Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-COMP WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Last reviewed: May 2026 · Scientific review: Boster Bio technical team
Western blot protocol sheet for COMP: expected band ~82.9 kDa, antibody A02443-1, and PMC-cited SDS-PAGE protocol steps
COMP Western blot protocol sheet — expected band ~82.9 kDa, antibody A02443-1, controls and PMC citations. Open the full COMP WB guide →

COMP Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~82.9 kDa
Observed band 110 kDa
Gel 8–10%
Negative control ⓘ siRNA / KO lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Glycosylated + Cleaved
Caveat N-glycosylation
Regulation Coagulation
Isoform 2 isoform(s)
Section 1

Real Curated COMP Western Blot Protocols

Literature-validated Western blot parameters for COMP — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.

Recommended Western blot protocol parameters
Sample / lysatehuman HepG2 , Lane 2: human Hacat , Lane 3: human CACO-2 , Lane 4: human 293T , Lane 5: rat cartilage , Lane 6: mouse cartilage . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-COMP antigen affinity purified polyclonal antibody (Catalog # A02443-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for COMP at approximately 110 kDa. The expected band size for COMP is at 83 kDa
Gel %8–10%
Load30 ug
Transfernitrocellulose membrane, 150 mA, 50–90 min
Membranenitrocellulose
Blocking5% non-fat milk / TBS, 1.5 h RT
Primary antibody0.5 µg/mL
Primary incubationovernight at 4 °C
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000
WashTBS-0.1% Tween, 3 × 5 min
DetectionECL
Exposure / imagingTanon 5200
Observed band110 kDa
Section 2

What Is the Expected COMP Western Blot Band Size?

COMP has an 82.9 kDa predicted backbone but runs at ~110 kDa on reducing blots due to N-linked glycosylation at two sites, with disulfide-linked pentamers appearing far higher if unreduced.

What am I looking at on my blot?
single band near 110 kDa under reducing conditionsthe glycosylated COMP monomer, elevated well above the 82.9 kDa predicted mass by N-linked glycosylation at Asn121 and Asn742
band smearing or fuzziness around 100-120 kDaheterogeneous carbohydrate loading across the two N-linked glycosylation sites broadening the monomer band
very high molecular weight band at or near the top of the gel or trapped in the stacking gelthe intact disulfide-linked pentamer running at roughly five times monomer mass because reduction was incomplete
little or no band in whole-cell lysateCOMP is secreted into the extracellular matrix, so a whole-cell lysate captures only the intracellular biosynthetic pool rather than the mature secreted protein
monomer band slightly smaller than the glycosylated full-length precursorremoval of the 20-residue signal peptide during secretion to yield the mature form
💡Expected COMP appearanceUnder reducing conditions COMP typically runs as a single monomer band at approximately 110 kDa, well above its 82.9 kDa predicted mass due to N-linked glycosylation at two sites and signal peptide cleavage.
How each factor affects band size
predicted mass (UniProt, 82.9 kDa)sets the unmodified polypeptide baseline before any processing or modification is accounted for
N-glycosylation at Asn121 and Asn742adds carbohydrate mass, shifting the observed reduced monomer up to roughly 110 kDa
signal peptide cleavage (residues 1-20)removes the N-terminal signal sequence during secretion, slightly lowering mature protein mass relative to the unprocessed precursor
disulfide-linked pentamer assemblyunder non-reducing or incompletely reduced conditions the intact oligomer migrates at roughly five times monomer mass near the top of the gel instead of the ~110 kDa monomer
isoforms 1 and 2 (alternative splicing)can shift the monomer band slightly relative to the canonical form, described only qualitatively since no per-isoform mass is defined
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateCOMP is secreted into the extracellular space and matrix, so whole-cell lysate largely misses the mature extracellular poolprobe conditioned media or an extracellular matrix extraction instead of relying solely on whole-cell lysate
Band higher than expectedincomplete reduction leaves the disulfide-linked pentamer or partial oligomeric intermediates intactincrease reducing agent concentration and boil the sample longer to fully resolve the ~110 kDa monomer
Broad smear instead of sharp bandheterogeneous glycosylation across the two N-linked sites produces a range of glycoform massestreat the sample with PNGase F to deglycosylate and sharpen the band, or extend separation on a lower-percentage gel
Multiple bandsco-migration of isoform 1 and isoform 2, or partially reduced oligomeric species alongside the monomerconfirm isoform identity with sequence-specific detection and verify complete denaturation and reduction of the sample
Fragments below expected sizeproteolytic degradation of the secreted extracellular matrix protein during tissue or matrix extractioninclude protease inhibitors and keep extracellular matrix samples cold and freshly processed

Sample controls for COMP Western blot

🧪For positive controls for COMP in Western blot, you can use cartilage tissue lysate or conditioned medium from a chondrocyte-derived cell line, since COMP (cartilage oligomeric matrix protein) is characteristically synthesized and secreted by chondrocytes.
Positive control: Cartilage tissue (chondrocytes)
Negative control: Non-cartilage cell line/tissue lacking COMP expression, or siRNA knockdown/KO
Loading controls: Run GAPDH and β-actin alongside a total-protein stain (e.g., stain-free gel, Ponceau S, or REVERT), though these cytoplasmic housekeeping proteins are a poor normalizer if probing secreted COMP in conditioned medium rather than whole-cell lysate.
⚠️Feasibility: As a secreted ECM protein, COMP gives little signal in standard whole-cell lysates, so conditioned medium or cartilage explant extracts are needed for a positive control, and since no HPA expression data are available for this gene, tissue/cell selection must rely on known cartilage-restricted biology rather than confirmed IHC or RNA-seq profiling.

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Section 3

Advanced COMP Western Blot Tips

Deeper troubleshooting and optimisation questions for COMP, answered from its protein features.

Why does COMP run near 110 kDa instead of 82.9 kDa?
Predicted mass reflects the unmodified 82.9 kDa monomer after signal peptide cleavage. Native COMP carries 2 N-glycosylation sites and forms 23 disulfide bonds within each subunit, both of which reduce SDS-PAGE mobility and shift the apparent band upward. A ~110 kDa apparent band is consistent with a fully glycosylated, disulfide-bonded monomer rather than degradation or a distinct isoform.
Can COMP alternative splicing create multiple bands?
COMP has 2 annotated isoforms produced by alternative splicing. If your antibody targets a region present in both isoforms, expect closely spaced bands rather than a single sharp band; if it targets an isoform-specific exon, only one band should appear. Confirm the immunogen location against isoform sequences before flagging extra bands as nonspecific.
Does N-glycosylation change the observed band size?
COMP carries 2 predicted N-glycosylation sites but no other listed modified residues. Removing sugars with PNGase F should collapse a diffuse ~110 kDa signal into a sharper band closer to the 82.9 kDa core polypeptide, confirming glycosylation rather than aggregation or isoform differences as the source of the shift.
What blocking buffer works best for COMP blots?
COMP is a heparin-binding glycoprotein, so casein/milk-based blockers, which themselves contain glycoproteins and lectin-reactive sugars, can cause nonspecific background or false signal. A BSA-based blocking buffer is generally preferable for clean detection of glycoproteins like COMP; validate with a no-primary-antibody control on the same membrane.
What transfer method to use for COMP Western blot?
COMP assembles into a large disulfide-linked pentamer with 23 disulfide bonds per subunit, so ensure full reduction and denaturation with DTT/beta-mercaptoethanol and heat before loading. For the reduced ~110 kDa monomer, standard wet/tank transfer is recommended; extend transfer time if any higher-order oligomer persists after reduction.
How should COMP signal be normalized for quantitation?
COMP is secreted into the extracellular matrix rather than retained intracellularly, so standard loading controls like GAPDH or actin are not appropriate for conditioned media or ECM extracts. Use a total protein stain, such as Ponceau S or a stain-free gel, applied to the same membrane for normalization instead.
What explains unexpected bands above or below 110 kDa?
Bands above 110 kDa likely reflect incompletely reduced pentamer subunits, since 23 disulfide bonds require thorough reducing conditions to fully dissociate. Bands below 110 kDa may indicate degradation fragments, consistent with COMP's location in the extracellular matrix where extracellular proteolysis can occur; verify with a fresh lysate and protease inhibitors.
Boster reagents

Best COMP Western Blot Antibodies

BosterBio's COMP antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.

Real WB data Western blot analysis of COMP using anti-COMP antibody (A02443-1). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human HepG2 whole cell lysates, Lane 2: human Hacat whole cell lysates, Lane 3: human CACO-2 whole cell lysates, Lane 4: human 293T whole cell lysates, Lane 5: rat cartilage tissue lysates, Lane 6: mouse cartilage tissue lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-COMP antigen affinity purified polyclonal antibody (Catalog # A02443-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for COMP at approximately 110 kDa. The expected band size for COMP is at 83 kDa.
Anti-COMP Antibody Picoband®
Cat # A02443-1

The anti-COMP antibody below is Boster's top-performing option for cartilage oligomeric matrix protein detection, extensively cited and rigorously validated by western blot, with specificity confirmed against negative-control tissue and orthogonal detection methods for reliable, reproducible results.

Which to pick: Only A02443-1 is catalogued for COMP, backed by an actual western blot validation image, so it's the clear choice; no alternative clones are currently listed for comparison.

Source: BosterBio COMP gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.

References

  1. UniProt Consortium. UniProt entry P49747.
  2. Human Protein Atlas. COMP tissue expression.